Integrative Proteomics Reveals Distinct Lipid Metabolic and Gut Microbiota-Associated Antidepressant Mechanisms of Two Herbal Medicines in a Chronic Stress Model
Restricted accessResearch articleFirst published online 2026
Integrative Proteomics Reveals Distinct Lipid Metabolic and Gut Microbiota-Associated Antidepressant Mechanisms of Two Herbal Medicines in a Chronic Stress Model
Depression is a prevalent and disabling mental disorder associated with increased suicide risk and impaired quality of life. Herbal medicines such as Hypericum perforatum L. (St. John’s Wort [SJW]) and Chaihu Shugan San (CSGS) have been widely used to treat depressive symptoms, yet their system-level molecular mechanisms remain incompletely understood. In this study, we applied a multi-omics strategy centered on quantitative proteomics, combined with metabolomics and microbiota profiling, to investigate the antidepressant mechanisms of CSGS and SJW in a chronic unpredictable mild stress rat model. Behavioral assessments confirmed that both treatments significantly alleviated depressive-like behaviors. Proteomic analysis identified 204 differentially expressed proteins (DEPs) in the CSGS group and 473 DEPs in the SJW group. Functional enrichment analyses suggested that CSGS was more closely associated with lipid metabolism, whereas SJW was linked to broader metabolic processes. Integrative metabolomic and microbiota analyses further supported these proteomics-driven pathway distinctions, with SJW showing stronger associations with gut microbiota alterations. CSGS and SJW alleviated depressive-like behaviors through divergent yet partially overlapping molecular mechanisms. These findings highlight the utility of multi-omics approaches for elucidating system-level mechanisms of complex herbal medicines.
AminN, LiuJ, BonnechereB, et al.Interplay of metabolome and gut microbiome in individuals with major depressive disorder vs control individuals. JAMA Psychiatry, 2023; 80(6):597–609; doi: 10.1001/jamapsychiatry.2023.0685
CacciaS, GobbiM. St. John’s wort components and the brain: Uptake, concentrations reached and the mechanisms underlying pharmacological effects. Curr Drug Metab, 2009; 10(9):1055–1065; doi: 10.2174/138920009790711878
4.
CaoY, FanX, ZangT, et al.Gut microbiota causes depressive phenotype by modulating glycerophospholipid and sphingolipid metabolism via the gut-brain axis. Psychiatry Res, 2025; 346:116392; doi: 10.1016/j.psychres.2025.116392
5.
Caro-RamírezJY, BazánLO, PiroOE, et al.Exploring zn(ii)-acetyl l-carnitine complex for simultaneous management of depression, chronic pain, and neuroprotection. J Inorg Biochem, 2025; 267:112857; doi: 10.1016/j.jinorgbio.2025.112857
6.
ChenG, ZhangW, ChenQ, et al.Geniposide exerts the antidepressant effect by affecting inflammation and glucose metabolism in a mouse model of depression. Chem Biol Interact, 2024; 400:111182; doi: 10.1016/j.cbi.2024.111182
7.
DalzielJE, ZobelG, DewhurstH, et al.A diet enriched with lacticaseibacillus rhamnosus hn001 and milk fat globule membrane alters the gut microbiota and decreases amygdala gaba a receptor expression in stress-sensitive rats. Int J Mol Sci, 2023; 24(13):10433; doi: 10.3390/ijms241310433
8.
DuY, LiX, ZhangS, et al.Transformations in plasma metabolic profiles of patients with major depression disorder during treatment. Metab Brain Dis, 2025; 40(7):265; doi: 10.1007/s11011-025-01682-y
9.
DuanJ, SunJ, MaX, et al.Association of escitalopram-induced shifts in gut microbiota and sphingolipid metabolism with depression-like behavior in Wistar-Kyoto rats. Transl Psychiatry, 2025; 15(1):54; doi: 10.1038/s41398-025-03277-8
10.
DuanL, SongL, QiuC, et al.Effect of the seh inhibitor auda on arachidonic acid metabolism and nf-κb signaling of rats with postpartum depression-like behavior. J Neuroimmunol, 2023; 385:578250; doi: 10.1016/j.jneuroim.2023.578250
11.
DubovskySL, GhoshBM, SerotteJC, et al.Psychotic depression: Diagnosis, differential diagnosis, and treatment. Psychother Psychosom, 2021; 90(3):160–177; doi: 10.1159/000511348
12.
FanM, JiangY, CaiC, et al.Green tea ameliorates depression-like behavior and cognitive impairment induced by high-fat diet and chronic mild stress. Phytother Res, 2025; 39(6):2707–2723; doi: 10.1002/ptr.8499
13.
FredrickF, AggarwalK, Reddy MedaAK, et al.Carnitine: Its crucial role in metabolic health and cardiovascular function. J Diet Suppl, 2025; 22(5):664–679; doi: 10.1080/19390211.2025.2530243
14.
Hypericum Depression Trial Study Group. Effect of hypericum perforatum (St John’s Wort) in major depressive Disordera randomized controlled trial. JAMA, 2002; 287(14):1807–1814; doi: 10.1001/jama.287.14.1807
15.
HawkinsKG, CasolaroC, BrownJA, et al.The microbiome and the gut-liver-brain axis for central nervous system clinical pharmacology: Challenges in specifying and integrating in vitro and in silico models. Clin Pharmacol Ther, 2020; 108(5):929–948; doi: 10.1002/cpt.1870
16.
Hernández-CachoA, García-GavilánJF, AtzeniA, et al.Multi-omics approach identifies gut microbiota variations associated with depression. NPJ Biofilms Microbiomes, 2025; 11(1):68; doi: 10.1038/s41522-025-00707-9
17.
JeongS, DavisCK, ChokkallaAK, et al.Fecal microbiota transplantation fails to impart the benefits of circadian-dependent intermittent fasting following ischemic stroke. J Cereb Blood Flow Metab, 2025; 45(4):779–789; doi: 10.1177/0271678x251319636
18.
JiangZM, WangFF, ZhaoYY, et al.Hypericum perforatum l. Attenuates depression by regulating akkermansia muciniphila, tryptophan metabolism and nfκb-nlrp2-caspase1-il1β pathway. Phytomedicine, 2024; 132:155847; doi: 10.1016/j.phymed.2024.155847
19.
KambeJ, MiyataS, LiC, et al.Xanthine-induced deficits in hippocampal behavior and abnormal expression of hemoglobin genes. Behav Brain Res, 2023; 449:114476; doi: 10.1016/j.bbr.2023.114476
20.
KendaM, Kočevar GlavačN, NagyM, et al.Medicinal plants used for anxiety, depression, or stress treatment: An update. Molecules, 2022; 27(18):6021; doi: 10.3390/molecules27186021
21.
KesslerRC, SoukupJ, DavisRB, et al.The use of complementary and alternative therapies to treat anxiety and depression in the United States. Am J Psychiatry, 2001; 158(2):289–294; doi: 10.1176/appi.ajp.158.2.289
22.
LanZF, YaoW, XieYC, et al.Oral troxerutin alleviates depression symptoms in mice by modulating gut microbiota and microbial metabolism. Mol Nutr Food Res, 2024; 68(3):e2300603; doi: 10.1002/mnfr.202300603
23.
LeeS, MunS, LeeYR, et al.Discovery and validation of acetyl-l-carnitine in serum for diagnosis of major depressive disorder and remission status through metabolomic approach. Front Psychiatry, 2022; 13:1002828; doi: 10.3389/fpsyt.2022.1002828
24.
LiuT, DengK, XueY, et al.Carnitine and depression. Front Nutr, 2022; 9:853058; doi: 10.3389/fnut.2022.853058
25.
LuZ, LiS, AaN, et al.Quantitative analysis of 20 purine and pyrimidine metabolites by hilic-ms/ms in the serum and hippocampus of depressed mice. J Pharm Biomed Anal, 2022; 219:114886; doi: 10.1016/j.jpba.2022.114886
26.
LuanX, WangX, ShiY, et al.Abnormalities of lipid metabolism in the progression and treatment of depression. Front Psychiatry, 2025; 16:1589663; doi: 10.3389/fpsyt.2025.1589663
Mayneris-PerxachsJ, Castells-NobauA, Arnoriaga-RodríguezM, et al.Microbiota alterations in proline metabolism impact depression. Cell Metab, 2022; 34(5):681–701.e610; doi: 10.1016/j.cmet.2022.04.001
29.
MokhtariA, IbrahimEC, GloaguenA, et al.Using multiomic integration to improve blood biomarkers of major depressive disorder: A case-control study. EBioMedicine, 2025; 113:105569; doi: 10.1016/j.ebiom.2025.105569
30.
MorlandC, NordengenK. N-acetyl-aspartyl-glutamate in brain health and disease. Int J Mol Sci, 2022; 23(3):1268; doi: 10.3390/ijms23031268
31.
Odaira-SatohT, NakagawasaiO, TakahashiK, et al.Ampk activation improves depression-like symptoms in olfactory bulbectomized mice by regulating microglia m1/m2 polarization in the hippocampus. Brain Behav Immun Health, 2025; 46:101008; doi: 10.1016/j.bbih.2025.101008
32.
ParkDI, DournesC, SillaberI, et al.Purine and pyrimidine metabolism: Convergent evidence on chronic antidepressant treatment response in mice and humans. Sci Rep, 2016; 6:35317; doi: 10.1038/srep35317
33.
QiuJ, HuSY, ShiGQ, et al.Changes in regional cerebral blood flow with Chaihu-Shugan-San in the treatment of major depression. Pharmacogn Mag, 2014; 10(40):503–508; doi: 10.4103/0973-1296.141775
34.
QuS, YuZ, ZhouY, et al.Gut microbiota modulates neurotransmitter and gut-brain signaling. Microbiol Res, 2024; 287:127858; doi: 10.1016/j.micres.2024.127858
35.
Rodríguez-LandaJF, ContrerasCM. A review of clinical and experimental observations about antidepressant actions and side effects produced by hypericum perforatum extracts. Phytomedicine, 2003; 10(8):688–699; doi: 10.1078/0944-7113-00340
36.
RuiL. Energy metabolism in the liver. Compr Physiol, 2014; 4(1):177–197; doi: 10.1002/cphy.c130024
37.
RushAJ, TrivediMH, WisniewskiSR, et al.Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: A star*d report. Am J Psychiatry, 2006; 163(11):1905–1917; doi: 10.1176/ajp.2006.163.11.1905
38.
SoczynskaJK, KennedySH, ChowCS, et al.Acetyl-l-carnitine and alpha-lipoic acid: Possible neurotherapeutic agents for mood disorders? Expert Opin Investig Drugs, 2008; 17(6):827–843; doi: 10.1517/13543784.17.6.827
39.
SunA, FanL, ZhangZ, et al.A metabolomics approach reveals the pharmacological effects and mechanisms of cistanche tubulosa stems and its combination with fluoxetine on depression in comorbid with sexual dysfunction. J Ethnopharmacol, 2025; 337(Pt 2):118891; doi: 10.1016/j.jep.2024.118891
40.
TanJ, LiX, ZhuY, et al.Antidepressant Shugan Jieyu capsule alters gut microbiota and intestinal microbiome function in rats with chronic unpredictable mild stress -induced depression. Front Pharmacol, 2022; 13:828595; doi: 10.3389/fphar.2022.828595
41.
TianT, MaoQ, XieJ, et al.Multi-omics data reveals the disturbance of glycerophospholipid metabolism caused by disordered gut microbiota in depressed mice. J Adv Res, 2022; 39:135–145; doi: 10.1016/j.jare.2021.10.002
42.
VeroneseN, StubbsB, SolmiM, et al.Acetyl-l-carnitine supplementation and the treatment of depressive symptoms: A systematic review and meta-analysis. Psychosom Med, 2018; 80(2):154–159; doi: 10.1097/psy.0000000000000537
43.
WangB, LuS, ZhangC, et al.Quantitative proteomic analysis of the liver reveals antidepressant potential protein targets of sinisan in a mouse cums model of depression. Biomed Pharmacother, 2020; 130:110565; doi: 10.1016/j.biopha.2020.110565
44.
WangR, HuX, LiuS, et al.Kaempferol-3-o-sophoroside (pcs-1) contributes to modulation of depressive-like behaviour in c57bl/6j mice by activating ampk. Br J Pharmacol, 2024a;181(8):1182–1202; doi: 10.1111/bph.16283
45.
WangY, JiaY, LiuX, et al.Effect of Chaihu-Shugan-San on functional dyspepsia and gut microbiota: A randomized, double-blind, placebo-controlled trial. J Ethnopharmacol, 2024b;322:117659; doi: 10.1016/j.jep.2023.117659
46.
WangYB, SongNN, DingYQ, et al.Neural plasticity and depression treatment. IBRO Neurosci Rep, 2023; 14:160–184; doi: 10.1016/j.ibneur.2022.09.001
47.
XiaN, WangJ, GuoQ, et al.Deciphering the antidepressant effects of Rosa Damascena essential oil mediated through the serotonergic synapse signaling pathway. J Ethnopharmacol, 2024; 328:118007; doi: 10.1016/j.jep.2024.118007
48.
XieJ, ZhongQ, WuWT, et al.Multi-omics data reveals the important role of glycerophospholipid metabolism in the crosstalk between gut and brain in depression. J Transl Med, 2023; 21(1):93; doi: 10.1186/s12967-023-03942-w
49.
XuD, QiuC, WangY, et al.Intranasal co-delivery of berberine and evodiamine by self-assembled thermosensitive in-situ hydrogels for improving depressive disorder. Int J Pharm, 2021; 603:120667; doi: 10.1016/j.ijpharm.2021.120667
50.
YeungKS, HernandezM, MaoJJ, et al.Herbal medicine for depression and anxiety: A systematic review with assessment of potential psycho-oncologic relevance. Phytother Res, 2018; 32(5):865–891; doi: 10.1002/ptr.6033
51.
YuL, ChenX, BaiX, et al.Microbiota alters and its correlation with molecular regulation underlying depression in pcos patients. Mol Neurobiol, 2024; 61(12):9977–9992; doi: 10.1007/s12035-023-03744-7
52.
ZhangB, JiJ, ZhangX, et al.Gan-mai-da-Zao decoction ameliorates depressive-like behaviors in cums mice via the microbiota-metabolism-inflammation axis. Phytomedicine, 2025; 145:157018; doi: 10.1016/j.phymed.2025.157018
53.
ZhangC, MoYY, FengSS, et al.Urinary metabonomics study of anti-depressive mechanisms of millettia speciosa champ on rats with chronic unpredictable mild stress-induced depression. J Pharm Biomed Anal, 2021; 205:114338; doi: 10.1016/j.jpba.2021.114338
ZhaoJ, YuanJ, ZhangY, et al.Bifidobacterium pseudonumeratum w112 alleviated depressive and liver injury symptoms induced by chronic unpredictable mild stress via gut-liver-brain axis. Front Nutr, 2024; 11:1421007; doi: 10.3389/fnut.2024.1421007
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
